Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 17.8312.958.485.937.80

What is the latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS is 17.83 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202517.83
Mar202412.95
Mar20238.48
Mar20225.93
Mar20217.80

How is EV/Core EBITDA of GLENMARK PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 17.83
37.68
Mar2024 12.95
52.71
Mar2023 8.48
43.00
Mar2022 5.93
-23.97
Mar2021 7.8 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,781.4 Cr 3.8% -1.5% 44.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹99,086.7 Cr 0.8% -9.1% -13.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.8%

-1.5%

44.3%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses